Anal High Grade Squamous Intraepithelial Lesion

2

Review clinical trials related to Anal High Grade Squamous Intraepithelial Lesion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Safety of Anal Curcumin

The purpose of this study is to see if curcumin can reverse anal high-grade squamous intraepithelial lesions (aHSIL) (high-grade anal precancerous cells or high-grade abnormal cells) in people living with HIV to avoid current treatments such as ablation (destroying abnormal cells with heat or surgical excision (cutting out the abnormal cells)), which have potential short- and long-term side effects.

Participants needed: 48
Trial details
Phase: Phase 1Age: 30+Biological sex: AllType: InterventionalSponsor: Lisa FlowersUpdated: May 18, 2026Locations: 2
Eligibility criteria

30 and older [+4]

Have a clinically significant chronic medical condition that is considered progr... [+6]

Status: Recruiting

Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants

This is a phase II double blind, placebo-controlled, randomized study of artesunate ointment for the treatment of HIV-negative men and women who have anal high grade squamous intraepithelial lesions (anal HSIL)

Participants needed: 48
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Frantz Viral Therapeutics, LLCUpdated: May 18, 2025Locations: 2
Eligibility criteria

Adult men and women age ≥ 18 years [+10]

Pregnant and nursing women [+7]